Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9350218rdf:typepubmed:Citationlld:pubmed
pubmed-article:9350218lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:9350218lifeskim:mentionsumls-concept:C0080103lld:lifeskim
pubmed-article:9350218lifeskim:mentionsumls-concept:C1319315lld:lifeskim
pubmed-article:9350218lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9350218lifeskim:mentionsumls-concept:C0439828lld:lifeskim
pubmed-article:9350218lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9350218lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9350218pubmed:issue9lld:pubmed
pubmed-article:9350218pubmed:dateCreated1997-11-19lld:pubmed
pubmed-article:9350218pubmed:abstractTextKi-67 is a protein associated with cell proliferation which is expressed in all phases of the cell cycle except Go. In the present study, Ki-67 expression in 255 human colorectal adenocarcinomas was examined using immunohistochemistry with the monoclonal antibody MIB-1. One hundred and fifty-seven (62%) cases had more than 50% positive tumour cells and 98 (38%) cases less than 50%. The tumours showed a wide range of Ki-67 expression, from 13% to 90%, which indicated a variation in proliferative activity. There was no significant relationship between Ki-67 expression and sex, age, tumour location, Dukes' stage, growth pattern, differentiation, DNA content, S-phase fraction or survival (p > 0.05). In conclusion, the proliferative activity as measured by Ki-67 antibody was not related to clinicopathology and prognosis in colorectal cancer.lld:pubmed
pubmed-article:9350218pubmed:languageenglld:pubmed
pubmed-article:9350218pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9350218pubmed:citationSubsetIMlld:pubmed
pubmed-article:9350218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9350218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9350218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9350218pubmed:statusMEDLINElld:pubmed
pubmed-article:9350218pubmed:monthSeplld:pubmed
pubmed-article:9350218pubmed:issn0903-4641lld:pubmed
pubmed-article:9350218pubmed:authorpubmed-author:JanssonAAlld:pubmed
pubmed-article:9350218pubmed:authorpubmed-author:SunX FXFlld:pubmed
pubmed-article:9350218pubmed:issnTypePrintlld:pubmed
pubmed-article:9350218pubmed:volume105lld:pubmed
pubmed-article:9350218pubmed:ownerNLMlld:pubmed
pubmed-article:9350218pubmed:authorsCompleteYlld:pubmed
pubmed-article:9350218pubmed:pagination730-4lld:pubmed
pubmed-article:9350218pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:meshHeadingpubmed-meshheading:9350218-...lld:pubmed
pubmed-article:9350218pubmed:year1997lld:pubmed
pubmed-article:9350218pubmed:articleTitleKi-67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas.lld:pubmed
pubmed-article:9350218pubmed:affiliationDepartment of Oncology, Linköping University, Sweden.lld:pubmed
pubmed-article:9350218pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9350218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9350218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9350218lld:pubmed